China Beta-lactam And Beta-lactamase Inhibitors Market (2025-2031) Outlook | Growth, Analysis, Trends, Value, Companies, Revenue, Share, Size, Forecast & Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, 2021 & 2031F

3.3 China Beta-lactam And Beta-lactamase Inhibitors Market - Industry Life Cycle

3.4 China Beta-lactam And Beta-lactamase Inhibitors Market - Porter's Five Forces

3.5 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume Share, By Disease, 2021 & 2031F

3.7 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of bacterial infections in China

4.2.2 Rising awareness about the importance of antibiotics

4.2.3 Growing investments in healthcare infrastructure in China

4.3 Market Restraints

4.3.1 Stringent regulations and approval processes for new antibiotics

4.3.2 Rising cases of antibiotic resistance

4.3.3 Competition from alternative treatment options like herbal medicines

6.1 China Beta-lactam And Beta-lactamase Inhibitors Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Drug Class, 2021 - 2031F

6.1.3 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Penicillin, 2021 - 2031F

6.1.4 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Cephalosporin, 2021 - 2031F

6.1.5 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Carbapenem, 2021 - 2031F

6.1.6 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Monobactam, 2021 - 2031F

6.1.7 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Combination, 2021 - 2031F

6.2 China Beta-lactam And Beta-lactamase Inhibitors Market, By Disease

6.2.1 Overview and Analysis

6.2.2 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Urinary Tract Infection (excluding cUTI), 2021 - 2031F

6.2.3 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Respiratory Infection, 2021 - 2031F

6.2.4 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Skin Infection, 2021 - 2031F

6.2.5 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Complicated Urinary Tract Infection (cUTI), 2021 - 2031F

6.2.6 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Complicated Intra-Abdominal Infections (cIAI), 2021 - 2031F

6.2.7 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Nosocomial Pneumonia, 2021 - 2031F

6.2.8 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Other Diseases, 2021 - 2031F

6.2.9 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Other Diseases, 2021 - 2031F

6.3 China Beta-lactam And Beta-lactamase Inhibitors Market, By Route Of Administration

6.3.1 Overview and Analysis

6.3.2 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Oral, 2021 - 2031F

6.3.3 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Intravenous, 2021 - 2031F

6.3.4 China Beta-lactam And Beta-lactamase Inhibitors Market Revenues & Volume, By Others, 2021 - 2031F

7.1 China Beta-lactam And Beta-lactamase Inhibitors Market Export to Major Countries

7.2 China Beta-lactam And Beta-lactamase Inhibitors Market Imports from Major Countries

8.1 Number of new antibiotic approvals by regulatory authorities

8.2 Antibiotic consumption trends in hospitals and clinics

8.3 Investments in research and development of new antibiotics

8.4 Number of reported cases of antibiotic-resistant bacterial infections

8.5 Percentage of healthcare professionals following antibiotic stewardship guidelines

9.1 China Beta-lactam And Beta-lactamase Inhibitors Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 China Beta-lactam And Beta-lactamase Inhibitors Market Opportunity Assessment, By Disease, 2021 & 2031F

9.3 China Beta-lactam And Beta-lactamase Inhibitors Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F

10.1 China Beta-lactam And Beta-lactamase Inhibitors Market Revenue Share, By Companies, 2024

10.2 China Beta-lactam And Beta-lactamase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters